Adrian Zuercher
Overview
Explore the profile of Adrian Zuercher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
215
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lauener R, Eigenmann P, Wassenberg J, Jung A, Denery-Papini S, Sjolander S, et al.
Clin Med Insights Pediatr
. 2017 Sep;
11:1179556517730018.
PMID: 28959122
To date, only few studies have assessed oral immunotherapy (OIT) for wheat allergy and often describe severe adverse reactions during therapy. We developed partially hydrolyzed wheat-based cereals (pHC), which were...
2.
Bioley G, Monnerat J, Lotscher M, Vonarburg C, Zuercher A, Corthesy B
Front Immunol
. 2017 Sep;
8:1043.
PMID: 28900429
Due to the increasing emergence of antibiotic-resistant strains of enteropathogenic bacteria, development of alternative treatments to fight against gut infections is a major health issue. While vaccination requires that a...
3.
Vinchi F, Costa Da Silva M, Ingoglia G, Petrillo S, Brinkman N, Zuercher A, et al.
Blood
. 2015 Dec;
127(4):473-86.
PMID: 26675351
Hemolytic diseases, such as sickle cell anemia and thalassemia, are characterized by enhanced release of hemoglobin and heme into the circulation, heme-iron loading of reticulo-endothelial system macrophages, and chronic inflammation....
4.
Longet S, Vonarburg C, Lotscher M, Miescher S, Zuercher A, Corthesy B
J Biol Chem
. 2014 Jun;
289(31):21617-26.
PMID: 24951593
Intravenous administration of polyclonal and monoclonal antibodies has proven to be a clinically valid approach in the treatment, or at least relief, of many acute and chronic pathologies, such as...
5.
Schabussova I, Hufnagl K, Tang M, Hoflehner E, Wagner A, Loupal G, et al.
PLoS One
. 2012 Jul;
7(7):e40271.
PMID: 22792257
Background: The hygiene hypothesis implies that microbial agents including probiotic bacteria may modulate foetal/neonatal immune programming and hence offer effective strategies for primary allergy prevention; however their mechanisms of action...
6.
Moussu H, Van Overtvelt L, Horiot S, Tourdot S, Airouche S, Zuercher A, et al.
Int Arch Allergy Immunol
. 2011 Dec;
158(1):35-42.
PMID: 22205338
Background: Enhancing clinical efficacy remains a major goal in allergen-specific immunotherapy. In this study, we tested three strains of bifidobacteria as candidate adjuvants for sublingual allergy vaccines. Methods: Probiotic candidates...